Deciphering the Impact of Rare Missense Variants in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer through Whole Exome Sequencing: A Computational Approach

Similar Items

• Investigating the structural impacts of a novel missense variant identified with whole exome sequencing in an Egyptian patient with propionic acidemia
  by: Ali Zaki Ibrahim, et al.
  Published: (2020-12-01)
• Comparative Atomistic Insights on Apo and ATP-I1171N/S/T in Nonsmall-Cell Lung Cancer
  by: Ambritha Balasundaram, et al.
  Published: (2023-11-01)
• Whole-exome sequencing reveals a rare missense variant in DTNA in an Iranian pedigree with early-onset atrial fibrillation
  by: Mahshid Malakootian, et al.
  Published: (2022-02-01)
• A computational examination of the therapeutic advantages of fourth-generation ALK inhibitors TPX-0131 and repotrectinib over third-generation lorlatinib for NSCLC with ALK F1174C/L/V mutations
  by: Ambritha Balasundaram, et al.
  Published: (2024-01-01)
• Unraveling the Structural Changes in the DNA-Binding Region of Tumor Protein p53 (<i>TP53</i>) upon Hotspot Mutation p53 Arg248 by Comparative Computational Approach
  by: Ambritha Balasundaram, et al.
  Published: (2022-12-01)